From the perspective of neuroinflammation, eltoprazine reduced the L‐DOPA‐induced upregulation of immediate‐early gene zif‐268 in striatum, delayed the onset of dyskinesia, and reserved the efficacy of L‐dopa.44, 45. Here, EGR1 is linked to drug-induced dyskinesia.